PHASE 3 STUDY OF ADXS11-001 ADMINISTERED FOLLOWING CHEMORADIATION AS ADJUVANT TREATMENT FOR HIGH RISK LOCALLY ADVANCED CERVICAL CANCER: AIM2CERV (Advaxis IMmunotherapy 2 prevent CERVical recurrence)

Project: Other project

Project Details

StatusFinished
Effective start/end date9/8/17 → 9/7/19